How genetic changes make some brain cancers more aggressiveOctober 2nd, 2010 - 4:13 pm ICT by ANI
Washington, Oct 02 (ANI): A study has provided new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and have explained why they may not respond to certain therapies.
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center led the study.
Glioblastoma has several subtypes, which are characterized by different genetic changes found in the tumor cells.
One common subtype is characterized by cells with increased signaling from a protein called platelet-derived growth factor receptor (PDGFR).
In the study, which involved screening patients’ tumor samples for PDGFR mutations, the researchers were surprised to find that almost half of all glioblastomas with excess copies of the PDGFR gene also had rearrangements in the gene itself, creating proteins that are continually turned on.
These rearrangements were either shortened forms of the protein or involved the fusion of the protein to another receptor.
Fusion genes have not been found in brain tumors previously but are well studied in certain types of leukemia, and more recently have been found in some solid tumors as well.
Much of the team’s work was made possible by data coming from The Cancer Genome Atlas (TCGA).
The presence of the rearrangements in the PDGFR gene suggest that these specific tumors have evolved to be dependent on signaling through this receptor, a target for several drugs under development.
The study has been published in the October 1 issue of the journal Genes ‘n’ Development. (ANI)
- Growth factor targeted by cancer drugs also prevents heart problem - Jan 12, 2010
- Worm studies shed light on protein associated with human cancers - Apr 23, 2011
- Most common adult brain cancer associated with gene deletion - Dec 23, 2010
- Deadly brain tumour's strength may be a weakness as well - Aug 15, 2010
- Full genetic blueprint of multiple prostate tumors unveiled - Feb 10, 2011
- Why certain anticancer cancer drugs cause heart failure - Jan 12, 2010
- Genetic change helps lung tumors spread to other parts of the body - Apr 07, 2011
- Potential driver of some aggressive prostate cancers found - Apr 05, 2011
- 'Self-seeding' of cancer cells may pave way for new therapies - Dec 25, 2009
- Gene fusion is the 'smoking gun' in the development of prostate cancer: Study - May 19, 2010
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- New hope in the fight against melanoma - Dec 14, 2010
- New potential target for breast cancer therapy identified - Dec 23, 2010
- Distinct subtypes of deadly brain cancer identified - Jan 20, 2010
- Gene behind rare skin cancer that heals itself discovered - Mar 11, 2011
Tags: brain cancer, brain cancers, brain tumors, fusion genes, genetic changes, glioblastomas, growth factor receptor, kettering cancer center, memorial sloan kettering, memorial sloan kettering cancer center, mutations, screening patients, sloan kettering cancer, sloan kettering cancer center, subtype, target, tcga, tumor cells, tumor samples, types of leukemia